Cell Isolation Market Report 2026-2031, By Product, Cell Type, and Geo

DESCRIPTION
TABLE OF CONTENTS
METHODOLOGY
DOWNLOAD PDF

Cell Isolation Market/ Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

USD 7.97 BN

MARKET SIZE, 2031

CELL ISOLATION MARKET SIZE, SHARE & GROWTH SNAPSHOT

cell-isolation-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global cell isolation market is projected to grow from USD 4.39 billion in 2026 to USD 7.97 billion by 2031, at a CAGR of 12.7% during the forecast period. The market was valued at USD 4.18 billion in 2025. The growth of the cell isolation market is driven by the increasing adoption of advanced cell separation technologies, along with rising demand for immune cell isolation, single-cell analysis, cell and gene therapy development, and translational research applications. Expanding use of cell isolation in drug discovery, clinical diagnostics, cancer research, stem cell research, and regenerative medicine is accelerating the adoption of cell separation workflows across research and clinical settings. Additionally, the growing focus on obtaining high-purity, viable, and application-specific cell populations is boosting demand for advanced instruments, magnetic beads, isolation kits, density gradient media, disposables, and automated cell processing solutions across the market.

KEY TAKEAWAYS

By Region

North America accounted for the largest share, at 43%, of the cell isolation market in 2025. The growth in this region is driven by strong biopharmaceutical and biotechnology R&D activity, advanced healthcare and research infrastructure, high investments in cell and gene therapy development, and the presence of leading market players promoting the adoption of advanced cell separation technologies.
By Product

By product, consumables accounted for the largest share, at 65%, of the cell isolation market in 2025. This dominance is driven by the frequent use of cell isolation reagents & kits, tissue dissociation reagents, media, sera, magnetic and fluorescent beads, and disposables across cell separation, enrichment, purification, and downstream analysis workflows.
By Technique

By technique, centrifugation-based cell isolation accounted for the largest share of the cell isolation market in 2025. This is attributed to its widespread use as a cost-effective, routine, and scalable method for separating cells based on size, density, and sedimentation properties across research, clinical, and bioprocessing workflows.
By End User

By end user, pharmaceutical & biotechnology companies accounted for the largest share of the cell isolation market in 2025. This dominance is driven by increasing R&D investments, growing use of isolated cells in drug discovery and development, expanding cell and gene therapy pipelines, and rising adoption of high-purity cell populations for translational research and therapeutic applications.
Competitive Landscape

Danaher (US), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (US) were identified as key players in the cell isolation market, given their strong market share and product portfolios.
Competitive Landscape

MagBio Genomics, Inc., Akadeum Life Sciences, and pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The cell isolation market is growing due to the increasing adoption of advanced mass spectrometry and immunoassay technologies, rising focus on precision medicine and biomarker research, expanding use of cell isolation in clinical diagnostics and drug discovery, and continuous advancements in high-throughput protein analysis and cell isolation data interpretation.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The cell isolation market is shifting from conventional manual separation methods toward advanced, automated, closed, and high-throughput cell separation platforms to improve purity, viability, and workflow reproducibility. Adoption of magnetic-activated cell separation, fluorescence-activated cell sorting, microfluidics, and label-free isolation technologies is increasing, enabling precise enrichment of immune cells, stem cells, circulating tumor cells, and primary cells from complex biological samples. Additionally, the growing demand for scalable, low-contamination, and GMP-compatible cell isolation workflows supported by automation, single-use consumables, and standardized isolation kits is accelerating market growth. Furthermore, enhanced cell recovery, reduced manual variability, faster sample processing, and broader integration with downstream applications such as single-cell analysis, cell therapy manufacturing, drug discovery, and clinical diagnostics are driving advances in this market.

cell-isolation-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

OPPORTUNITIES

Impact
Level

Growing demand for GMP-grade cell isolation products
Adoption of microfluidic and label-free isolation technologies

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The expansion of cell and gene therapy workflows is significantly strengthening the cell isolation market by increasing the need for high-purity, viable, and functionally intact cell populations. Cell isolation is a critical step in workflows involving T cells, NK cells, stem cells, hematopoietic cells, and other therapeutic cell types used in research, process development, and clinical manufacturing. As cell therapy developers move from early-stage research to clinical and commercial-scale manufacturing, demand is increasing for automated, closed, and GMP-compatible isolation systems, magnetic beads, separation kits, and single-use consumables that support reproducibility, sterility, and scalability.

The high cost of cell isolation instruments and consumables remains a major restraint for the market. Advanced cell sorters, automated magnetic separation systems, closed cell processing platforms, and microfluidic isolation systems require significant capital investment, along with ongoing costs for maintenance, calibration, software, service contracts, and trained personnel. In addition, recurring expenditure on magnetic beads, antibody-based kits, density gradient media, single-use disposables, and GMP-grade reagents increases the overall cost per sample or batch. This creates barriers to adoption for small laboratories, academic institutes, and cost-sensitive clinical or research facilities.

The growing demand for GMP-grade cell isolation products presents a strong opportunity for the cell isolation market as clinical and manufacturing workflows increasingly require validated, sterile, and reproducible products. Cell and gene therapy developers need isolation reagents, magnetic beads, buffers, single-use kits, and closed processing systems that can support regulatory expectations and minimize contamination risk. This is particularly important for immune cell isolation, stem cell enrichment, and therapeutic cell processing, where product quality, cell viability, and consistency directly affect downstream performance. Suppliers offering scalable, GMP-compliant, and workflow-integrated solutions are well-positioned to benefit from this demand.

Balancing purity, yield, viability, and cost remains a key challenge in the cell isolation market. Highly selective isolation methods can improve purity but may reduce cell recovery, increase processing time, or affect cell viability, especially when working with fragile primary cells, rare cell populations, or limited clinical samples. Similarly, automated and closed systems can improve reproducibility and contamination control but may increase workflow costs. End users must optimize isolation protocols based on application needs, whether for research, diagnostics, single-cell analysis, or cell therapy manufacturing. Achieving consistent results while maintaining affordability and scalability remains a major challenge across workflows.

CELL ISOLATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Sepax C-Pro and Sefia systems applied in automated, functionally closed cell isolation and processing workflows for cell therapy development and commercialization	Closed-system cell processing \| Reduced contamination risk \| Improved workflow reproducibility \| Supports clinical-scale cell therapy manufacturing
	Gibco CTS Dynabeads and CTS DynaCellect Magnetic Separation System applied in T-cell isolation, activation, and bead removal workflows for cell therapy development and manufacturing	Scalable immune cell isolation \| Improved T-cell activation workflow \| GMP-ready cell therapy processing \| Reduced manual handling

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The cell isolation market ecosystem comprises raw material suppliers, product providers, end users, and regulatory authorities. Raw material suppliers, including Bio-Techne, Actylis, and PELO Biotech, support the market by providing critical inputs such as antibodies, enzymes, media components, buffers, sera, beads, and other materials used in the development of cell isolation products. Product providers such as Thermo Fisher Scientific, Sony Biotechnology, Merck, and Danaher supply instruments, reagents, kits, beads, media, disposables, and automated platforms used across cell separation, enrichment, purification, and downstream processing workflows. Regulatory authorities, including the US FDA, CDSCO, OLAW, MHRA, ANVISA, and Health Canada, establish requirements for product quality, safety, validation, sterility, and compliance, particularly for clinical research and cell therapy manufacturing applications. End users, including Amgen, Novartis, Merck, MIT, and other biopharmaceutical companies, research institutes, clinical laboratories, and cell therapy developers, utilize cell isolation solutions for drug discovery, immunology research, cancer biology, stem cell research, regenerative medicine, clinical diagnostics, and cell and gene therapy workflows.

cell-isolation-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

cell-isolation-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

In 2025, the consumables segment dominated the cell isolation market. This leadership is driven by the recurring use of cell isolation reagents & kits, tissue dissociation reagents, media, sera, magnetic beads, fluorescent beads, buffers, and disposables across cell separation and enrichment workflows. These products are widely used in immune cell isolation, stem cell research, primary cell isolation, clinical diagnostics, drug discovery, and cell therapy development. The need for high-purity, viable, and reproducible cell populations continues to support steady demand for consumables across research and clinical settings.

In 2025, the human cells segment dominated the cell isolation market, supported by the growing use of human-derived immune cells, stem cells, leukocytes, circulating tumor cells, and differentiated cells in drug discovery, translational research, clinical diagnostics, and cell and gene therapy development. Human cells are widely used for disease modeling, biomarker discovery, immunology studies, cancer research, and personalized medicine applications. The increasing adoption of single-cell analysis and GMP-compatible cell processing further strengthens the demand for human cell isolation products.

In 2025, pharmaceutical & biotechnology companies dominated the cell isolation market due to their strong focus on R&D, drug discovery, immuno-oncology, regenerative medicine, and cell and gene therapy development. These companies widely use cell isolation technologies to obtain purified and viable cell populations for target validation, mechanism-of-action studies, biomarker analysis, preclinical research, and therapeutic manufacturing workflows. Rising investment in advanced cell-based research and increasing demand for scalable, automated, and reproducible cell isolation solutions are driving demand across this end-user group.

CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX

In the cell isolation market company evaluation matrix, Danaher Corporation is positioned as a star player due to its strong presence across cell separation, flow cytometry, and automated cell processing workflows. Through Cytiva and Beckman Coulter Life Sciences, the company offers a broad range of cell sorters, flow cytometry platforms, automated cell processing systems, closed-system cell isolation solutions, and workflow-enabling consumables used in research, clinical, and cell therapy applications. Its global reach, comprehensive portfolio, strong installed base, and consistent focus on automation, scalability, and GMP-compatible workflows make it a preferred partner for pharmaceutical, biotechnology, academic, and clinical research organizations. Sony Corporation is considered an emerging leader in this market. The company is strengthening its position through advanced flow cytometry and cell-sorting platforms that enable high-purity cell isolation, immune profiling, single-cell analysis, and translational research workflows. Its focus on compact, high-performance cell-sorting technologies and on expanding application relevance across immunology, oncology, and cell-based research is driving increased adoption, thereby strengthening its market position.

cell-isolation-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Danaher Corporation (US)
Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (US)
BD (US)
Sartorius AG (Germany)
Agilent Technologies, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
QIAGEN (Netherlands)
F. Hoffmann-La Roche Ltd (Switzerland)
Revvity (US)
Corning Incorporated (US)
Lonza (Switzerland)
Bio-Techne (US)
Terumo Corporation (Japan)
Miltenyi Biotec (Germany)
Takara Bio Inc. (Japan)
GenScript (US)
Sony Group Corporation (Japan)
Alfa Laval (Sweden)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 4.18 Billion
Market Forecast in 2026 (Value)	USD 4.39 Billion
Market Forecast in 2031 (Value)	USD 7.97 Billion
Growth Rate	CAGR of 12.7% from 2026-2031
Years Considered	2024-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD Billion)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Product: Consumables Instruments By Cell Type: Human Cells Animal Cells By Cell Source: Blood & Blood-derived Samples Adipose Tissue Bone Marrow Cord Blood/Embryonic Stem Cells Other Cell Sources By Technique: Centrifugation-based Cell Isolation Surface Marker-based Cell Isolation Filtration-based Cell Isolation Microfluidics and Label-free Cell Isolation By Application: Research Applications Drug Discovery and Development In Vitro Diagnostics CGT Manufacturing By End User: Pharmaceutical & Biotechnology Companies Academic & Research Institutes Hospitals & Diagnostic Laboratories Other End Users
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa

WHAT IS IN IT FOR YOU: CELL ISOLATION MARKET REPORT CONTENT GUIDE

cell-isolation-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Rest of Europe Breakdown	Country-level market sizing and growth forecasts (Switzerland, Sweden, Turkey, the Netherlands, Norway, Poland, Portugal, Romania, Denmark, Estonia, Finland, the Czech Republic, Greece, Austria, Belgium, and Russia)	Provides granular country-level insights, enabling clients to prioritize high-growth markets
Company Evaluation	Detailed analysis and profiling of top five market players Portfolio assessment of top five companies	Delivers visibility into competitors, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions

RECENT DEVELOPMENTS

March 2026 : Danaher and SR-TIGET launched a collaboration, Danaher Beacon, to advance next-generation genomic medicine platforms. The initiative focuses on lentiviral gene transfer and targeted gene editing of hematopoietic stem cells, with an emphasis on automating cell manipulation and improving processes across cell and gene therapy workflows.
October 2025 : Alfa Laval launched the Culturefuge 200 B separator for medium-scale high-density fermentation harvesting. The system uses Hermetic Design and Bactofuge technology for gentle, continuous separation and is designed for cell harvesting, microbial cell separation, cell debris separation, probiotic separation, and suspended protein separation.
January 2025 : Merck acquired HUB Organoids to expand its next-generation biology and 3D cell culture portfolio. The acquisition added organoid model generation, assay development, and high-throughput screening capabilities, strengthening Merck’s cell culture and cell-based drug discovery offerings.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

MARKET OVERVIEW

Explore transformative shifts driving cell isolation market growth and innovation opportunities.

4.2.1.1

EXPANSION OF CELL AND GENE THERAPY WORKFLOWS

4.2.1.2

RISING DEMAND FOR IMMUNE CELL ISOLATION

4.2.1.3

GROWING ADOPTION OF SINGLE-CELL ANALYSIS

4.2.1.4

SHIFT TOWARD AUTOMATED AND CLOSED ISOLATION SYSTEMS

4.2.2.1

HIGH COST OF INSTRUMENTS AND CONSUMABLES

4.2.2.2

LOSS OF CELL VIABILITY AND RECOVERY DURING ISOLATION

4.2.3.1

GROWING DEMAND FOR GMP-GRADE CELL ISOLATION PRODUCTS

4.2.3.2

ADOPTION OF MICROFLUIDIC AND LABEL-FREE ISOLATION TECHNOLOGIES

4.2.4.1

SCALING RESEARCH WORKFLOWS TO GMP MANUFACTURING

4.2.4.2

BALANCING PURITY, YIELD, VIABILITY, AND COST

4.3

UNMET NEEDS & WHITE SPACES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS

INDUSTRY TRENDS

Navigate competitive forces shaping biotech and healthcare markets with strategic insights on pricing and trade.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

INTENSITY OF COMPETITIVE RIVALRY

5.1.2

BARGAINING POWER OF SUPPLIERS

5.1.3

BARGAINING POWER OF BUYERS

5.1.4

THREAT OF SUBSTITUTES

5.1.5

THREAT OF NEW ENTRANTS

5.2

MACROECONOMIC OUTLOOK

5.2.2

GDP TRENDS & FORECAST

5.2.3

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.4

TRENDS IN GLOBAL BIOTECH INDUSTRY

5.4.1

ROLE OF PLAYERS IN ECOSYSTEM

5.5.1

AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025

5.5.2

AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025

5.5.3

AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025

5.5.4

AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025

5.6.1

IMPORT SCENARIO (HS CODE 3822.00)

5.6.2

EXPORT SCENARIO (HS CODE 3822.00)

5.7

KEY CONFERENCES & EVENTS, 2026–2027

5.8

TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.9

INVESTMENT & FUNDING SCENARIO

5.10.1

MICROFLUIDIC CELL SORTING IMPROVES CAR-T STARTING MATERIAL QUALITY

5.10.2

CLOSED-SYSTEM CELL ENRICHMENT SUPPORTS NK CELL MANUFACTURING

5.10.3

MICROFLUIDIC ISOLATION ENHANCES CTC RECOVERY IN PANCREATIC CANCER

5.11

IMPACT OF 2025 US TARIFFS ON CELL ISOLATION MARKET

5.11.3

PRICE IMPACT ANALYSIS

5.11.4

IMPACT ON COUNTRY/REGION

5.11.5

IMPACT ON END-USE INDUSTRIES

5.11.5.1

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

5.11.5.2

ACADEMIC & RESEARCH INSTITUTES

5.11.5.3

HOSPITALS & DIAGNOSTIC LABORATORIES

TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

AI-driven cell isolation technologies revolutionize market with innovative patents and transformative future applications.

6.1.1.1

CENTRIFUGATION-BASED TECHNIQUES

6.1.1.2

MAGNETIC CELL ISOLATION

6.1.1.3

FLUORESCENCE-ACTIVATED CELL SORTING

6.1.1.4

ACOUSTOFLUIDIC CELL ISOLATION

6.1.1.5

FILTRATION & SIZE-BASED CELL ISOLATION

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.2

CELL IMAGING TECHNOLOGIES

6.1.2.3

AI-ENABLED IMAGE-BASED SORTING

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

SINGLE-CELL SEQUENCING

6.1.3.2

CRISPR & GENE EDITING

6.1.3.3

3D CELL CULTURE & ORGANOIDS

6.3.2

NUMBER OF PATENTS FILED, BY DOCUMENT TYPE

6.3.3

LIST OF KEY PATENTS

6.5

IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET

6.5.1

TOP USE CASES & MARKET POTENTIAL

6.5.2

BEST PRACTICES IN AI-ENABLED CELL ISOLATION WORKFLOWS

6.5.3

CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET

6.5.4

INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS

6.5.5

CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Unlock strategic insights into buyer dynamics and unmet needs across diverse industries.

102

7.1

DECISION-MAKING PROCESS

7.2

BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA

7.2.1

KEY STAKEHOLDERS IN BUYING PROCESS

7.2.2

KEY BUYING CRITERIA, BY END USER

7.3

ADOPTION BARRIERS & INTERNAL CHALLENGES

7.4

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

SUSTAINABILITY & REGULATORY LANDSCAPE

Navigate global sustainability with insights on regional regulations and compliance standards.

106

8.1

REGIONAL REGULATIONS & COMPLIANCE

8.1.1

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

8.1.2.4

REST OF THE WORLD

8.2

SUSTAINABILITY INITIATIVES

8.3

IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES

8.4

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CELL ISOLATION MARKET, BY PRODUCT

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 102 Data Tables

115

9.2.1.1

CELL ISOLATION REAGENTS & KITS

9.2.1.1.1

EXPANSION OF DOWNSTREAM SINGLE-CELL GENOMICS TO DRIVE MARKET

9.2.1.2

TISSUE DISSOCIATION REAGENTS & KITS

9.2.1.2.1

INFLUX OF SOLID TUMOR ONCOLOGY PROFILING AND PRIMARY CELL CULTURE DERIVATIONS TO DRIVE GROWTH

9.2.1.3

OTHER REAGENTS & KITS

9.2.2.1

RISING FOCUS ON VIABLE, REPRODUCIBLE, AND CLINICALLY COMPATIBLE ISOLATED CELL WORKFLOWS TO FUEL MARKET

9.2.3.1

GROWING DEMAND FOR BEADS IN T-CELL AND STEM CELL ISOLATION TO DRIVE MARKET GROWTH

9.2.4.1

GROWING GOVERNMENT INVESTMENTS IN RESEARCH TO AID MARKET GROWTH

9.3.1.1

GROWING USE IN PHARMA-BIOTECH INDUSTRY TO BOOST MARKET

9.3.2.1

RISE IN CELL-BASED RESEARCH INITIATIVES TO AUGMENT GROWTH

9.3.3

MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS

9.3.3.1

BOOMING USE IN RESEARCH FOR T-CELL AND STEM CELL ISOLATION TO DRIVE MARKET

9.3.4.1

RISING NEED TO ENSURE GOOD MANUFACTURING PRACTICE STANDARDS AND REGULATIONS TO BOOST MARKET

CELL ISOLATION MARKET, BY CELL TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 30 Data Tables

166

10.2.1

DIFFERENTIATED CELLS

10.2.1.1

RISING USE OF MATURE HUMAN CELL POPULATIONS IN TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO FUEL GROWTH

10.2.2.1

RISE IN GRANTS AND FUNDING FOR STEM CELL RESEARCH TO DRIVE MARKET

10.3.1

GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH

CELL ISOLATION MARKET, BY CELL SOURCE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables

182

11.2

BLOOD & BLOOD-DERIVED SAMPLES

11.2.1

GROWING USE OF IMMUNE CELL ISOLATION FROM BLOOD-DERIVED SAMPLES TO DRIVE MARKET

11.3.1

INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET

11.4.1

GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH

11.5

CORD BLOOD/EMBRYONIC STEM CELLS

11.5.1

GROWING USE OF STEM AND PROGENITOR CELL ISOLATION IN REGENERATIVE MEDICINE AND CELL THERAPY RESEARCH TO SUPPORT MARKET GROWTH

CELL ISOLATION MARKET, BY TECHNIQUE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables

201

12.2

CENTRIFUGATION-BASED CELL ISOLATION

12.2.1

RISING DEMAND FOR SCALABLE, AUTOMATED, AND CLOSED CELL PREPARATION WORKFLOWS TO FUEL MARKET

12.3

SURFACE MARKER-BASED CELL ISOLATION

12.3.1

GROWING NEED FOR MARKER-SPECIFIC AND HIGH-PURITY CELL POPULATIONS TO PROPEL MARKET

12.4

FILTRATION-BASED CELL ISOLATION

12.4.1

NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET

12.5

MICROFLUIDICS & LABEL-FREE CELL ISOLATION

12.5.1

HIGH DEMAND FOR ONCOLOGY RESEARCH TO SUPPORT SEGMENTAL GROWTH

CELL ISOLATION MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 65 Data Tables

216

13.2

RESEARCH APPLICATIONS

13.2.1

BIOMOLECULE ISOLATION

13.2.1.1

INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET

13.2.2.1

PRECISION ONCOLOGY AND RARE TUMOR CELL ANALYSIS TO DRIVE MARKET

13.2.3

STEM CELL RESEARCH

13.2.3.1

RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH

13.2.4

REGENERATIVE MEDICINE

13.2.4.1

EXPANDING STEM CELL AND TRANSLATIONAL THERAPY RESEARCH TO SUPPORT MARKET

13.2.5

OTHER RESEARCH APPLICATIONS

13.3

DRUG DISCOVERY & DEVELOPMENT

13.3.1

RISING ADOPTION OF CELL-BASED DRUG DISCOVERY AND PRECISION THERAPEUTICS TO PROPEL MARKET

13.4

IN VITRO DIAGNOSTICS

13.4.1

RISING ADOPTION OF LIQUID BIOPSY AND PRECISION DIAGNOSTICS TO PROPEL MARKET

13.5.1

EXPANSION OF GMP-COMPLIANT CGT MANUFACTURING CAPACITY TO PROPEL MARKET

CELL ISOLATION MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables

250

14.2

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

14.2.1

INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH

14.3

ACADEMIC & RESEARCH INSTITUTES

14.3.1

HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT

14.4

HOSPITALS & DIAGNOSTIC LABORATORIES

14.4.1

RISING DEMAND FOR ENRICHED CLINICAL CELL POPULATIONS IN ONCOLOGY AND HEMATOLOGY DIAGNOSTICS TO DRIVE MARKET

CELL ISOLATION MARKET, BY REGION

Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 315 Data Tables.

265

15.2.1.1

STRONG BIOPHARMA R&D AND ADVANCED CELL SORTING ADOPTION TO DRIVE MARKET

15.2.2.1

EXPANDING CELL THERAPY MANUFACTURING AND REGENERATIVE MEDICINE RESEARCH TO PROPEL MARKET

15.3.1.1

STRONG CELL & GENE THERAPY TRANSLATION AND GMP-READY AUTOMATED CELL PROCESSING TO AID MARKET GROWTH

15.3.2.1

EXPANDING ADVANCED THERAPY INFRASTRUCTURE AND GMP-COMPATIBLE CELL PROCESSING WORKFLOWS TO DRIVE MARKET

15.3.3.1

EXPANDING BIOTHERAPY RESEARCH AND CELL & GENE THERAPY INFRASTRUCTURE TO DRIVE MARKET

15.3.4.1

EXPANDING ADVANCED THERAPY TRIALS AND EX VIVO GENE THERAPY CAPABILITIES TO DRIVE MARKET

15.3.5.1

HOSPITAL-BASED CAR-T MANUFACTURING AND GMP-COMPATIBLE CELL PROCESSING WORKFLOWS TO AID GROWTH

15.4.1.1

EXPANDING CELL THERAPY PIPELINES AND REGENERATIVE MEDICINE COMMERCIALIZATION TO BOOST MARKET

15.4.2.1

IPSC RESEARCH LEADERSHIP, REGENERATIVE MEDICINE COMMERCIALIZATION, AND DOMESTIC CELL THERAPY MANUFACTURING EXPANSION TO DRIVE MARKET GROWTH

15.4.3.1

BIOE3-LED BIOMANUFACTURING AND TRANSLATIONAL RESEARCH EXPANSION PROPEL MARKET

15.4.4.1

HOSPITAL-LINKED GMP CELL THERAPY CAPACITY, REGENERATIVE MEDICINE TRIALS, AND TRANSLATIONAL RESEARCH INFRASTRUCTURE TO FUEL MARKET

15.4.5.1

BIOPROCESSING INFRASTRUCTURE EXPANSION AND REGENERATIVE MEDICINE FOCUS TO SUPPORT MARKET GROWTH

15.4.6

REST OF ASIA PACIFIC

15.5.1.1

ADVANCED THERAPY REGULATION AND ONCOLOGY RESEARCH STRENGTH TO DRIVE MARKET

15.5.2.1

REGULATORY STRENGTHENING AND PHARMACEUTICAL INFRASTRUCTURE GROWTH TO SUPPORT THE MARKET

15.5.3

REST OF LATIN AMERICA

15.6.1.1.1

LOCAL ADVANCED THERAPY MANUFACTURING AND PRECISION MEDICINE INVESTMENT TO BOOST MARKET

15.6.1.2.1

STEM CELL RESEARCH INFRASTRUCTURE AND REGENERATIVE MEDICINE STANDARDS TO AID MARKET GROWTH

15.6.1.3

REST OF GCC COUNTRIES

15.6.2

REST OF MIDDLE EAST

15.7.1

POPULATION-SPECIFIC ONCOLOGY RESEARCH AND INFECTIOUS DISEASE STUDIES TO PROPEL MARKET

COMPETITIVE LANDSCAPE

Uncover strategic moves and market dominance of key players in the cell isolation industry.

409

16.2

KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2023–APRIL 2026

16.2.1

OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026

16.3

REVENUE ANALYSIS, 2021–2025

16.4

MARKET SHARE ANALYSIS, 2025

16.5

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025

16.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

16.5.5.1

COMPANY FOOTPRINT

16.5.5.2

REGION FOOTPRINT

16.5.5.3

PRODUCT FOOTPRINT

16.5.5.4

CELL TYPE FOOTPRINT

16.5.5.5

END-USER FOOTPRINT

16.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

16.6.1

PROGRESSIVE COMPANIES

16.6.2

RESPONSIVE COMPANIES

16.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

16.6.5.1

DETAILED LIST OF KEY STARTUP/SME PLAYERS

16.6.5.2

COMPETITIVE BENCHMARKING OF STARTUPS/SMES

16.7

COMPANY VALUATION & FINANCIAL METRICS

16.8

BRAND/PRODUCT COMPARISON

16.9

COMPETITIVE SCENARIO

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

430

17.1.1

DANAHER CORPORATION

17.1.1.1

BUSINESS OVERVIEW

17.1.1.2

PRODUCTS OFFERED

17.1.1.3

RECENT DEVELOPMENTS

17.1.1.4.2

STRATEGIC CHOICES

17.1.1.4.3

WEAKNESSES & COMPETITIVE THREATS

17.1.3

THERMO FISHER SCIENTIFIC INC.

17.1.4

BECTON, DICKINSON AND COMPANY

17.1.5

AGILENT TECHNOLOGIES, INC.

17.1.7

BIO-RAD LABORATORIES, INC.

17.1.9

F. HOFFMANN-LA ROCHE LTD.

17.1.11

CORNING INCORPORATED

17.1.14

TERUMO CORPORATION

17.2.1

PROMEGA CORPORATION

17.2.2

CELL SIGNALING TECHNOLOGY, INC.

17.2.4

APPLIED CELLS, INC.

17.2.5

STEMCELL TECHNOLOGIES

17.2.7

PROTEINTECH GROUP, INC.

17.2.8

MAGBIO GENOMICS, INC.

17.2.9

AKADEUM LIFE SCIENCES

17.2.10

PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG

17.2.11

INVENT BIOTECHNOLOGIES, INC.

RESEARCH METHODOLOGY

505

18.1.1.1

KEY DATA FROM SECONDARY SOURCES

18.1.2.1

KEY DATA FROM PRIMARY SOURCES

18.1.2.2

KEY PRIMARY PARTICIPANTS

18.1.2.3

BREAKDOWN OF PRIMARY INTERVIEWS

18.1.2.4

KEY INDUSTRY INSIGHTS

18.2

MARKET SIZE ESTIMATION

18.2.1

GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025

18.2.2

SEGMENTAL MARKET SIZE ESTIMATION

18.3

MARKET GROWTH RATE PROJECTIONS

18.6

RESEARCH ASSUMPTIONS

18.7

RESEARCH LIMITATIONS & RISK ASSESSMENT

19.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

19.3

CUSTOMIZATION OPTIONS

TABLE 1

CELL ISOLATION MARKET: INCLUSIONS & EXCLUSIONS

TABLE 2

CELL ISOLATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS

TABLE 3

CELL ISOLATION MARKET: PORTER’S FIVE FORCES

TABLE 4

CELL ISOLATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM

TABLE 5

AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025 (USD)

TABLE 6

AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025 (USD)

TABLE 7

AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025 (USD)

TABLE 8

AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025 (USD)

TABLE 9

IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)

TABLE 10

EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)

TABLE 11

CELL ISOLATION MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027

TABLE 12

RECIPROCAL TARIFF RATES ADJUSTED BY US

TABLE 13

CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES

TABLE 14

NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025

TABLE 15

LIST OF KEY PATENTS IN CELL ISOLATION MARKET, 2023–2025

TABLE 16

CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET

TABLE 17

CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES IN CELL ISOLATION MARKET

TABLE 18

INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT

TABLE 19

KEY BUYING CRITERIA, BY END USER

TABLE 20

NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 21

EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 22

ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 23

REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 24

CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 25

CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 26

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 27

EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 28

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 29

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 30

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 31

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 32

CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 33

CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION)

TABLE 34

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 35

EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 36

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 37

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 38

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION)

TABLE 39

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 40

CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 41

CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 42

NORTH AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 43

EUROPE: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 44

ASIA PACIFIC: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 45

LATIN AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 46

MIDDLE EAST: CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 47

GCC COUNTRIES: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 48

TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 49

NORTH AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 50

EUROPE: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 51

ASIA PACIFIC: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 52

LATIN AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 53

MIDDLE EAST: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 54

GCC COUNTRIES: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 55

OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 56

NORTH AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 57

EUROPE: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 58

ASIA PACIFIC: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 59

LATIN AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 60

MIDDLE EAST: OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 61

GCC COUNTRIES: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 62

CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION)

TABLE 63

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 64

EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 65

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 66

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 67

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION)

TABLE 68

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 69

CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION)

TABLE 70

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 71

EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 72

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 73

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 74

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION)

TABLE 75

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 76

CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION)

TABLE 77

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 78

EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 79

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 80

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 81

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION)

TABLE 82

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 83

CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 84

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 85

EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 86

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 87

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 88

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 89

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 90

CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 91

CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION)

TABLE 92

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 93

EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 94

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 95

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 96

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION)

TABLE 97

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 98

CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 99

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 100

EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 101

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 102

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 103

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 104

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 105

CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION)

TABLE 106

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 107

EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 108

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 109

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 110

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION)

TABLE 111

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 112

CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)

TABLE 113

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 114

EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 115

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 116

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 117

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)

TABLE 118

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 119

OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 120

NORTH AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 121

EUROPE: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 122

ASIA PACIFIC: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 123

LATIN AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 124

MIDDLE EAST: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 125

GCC COUNTRIES: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 126

CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 127

CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 128

NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 129

EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 130

ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 131

LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 132

MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 133

GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 134

CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 135

CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 136

NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 137

EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 138

ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 139

LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 140

MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 141

GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 142

CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 143

NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 144

EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 145

ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 146

LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 147

MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 148

GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 149

CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 150

NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 151

EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 152

ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 153

LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 154

MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 155

GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 156

CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 157

CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION)

TABLE 158

NORTH AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 159

EUROPE: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 160

ASIA PACIFIC: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 161

LATIN AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 162

MIDDLE EAST: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION)

TABLE 163

GCC COUNTRIES: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 164

CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION)

TABLE 165

NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 166

EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 167

ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 168

LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 169

MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION)

TABLE 170

GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 171

CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION)

TABLE 172

NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 173

EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 174

ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 175

LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 176

MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION)

TABLE 177

GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 178

CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 179

NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 180

EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 181

ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 182

LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 183

MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION)

TABLE 184

GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 185

CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION)

TABLE 186

NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 187

EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 188

ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 189

LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 190

MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION)

TABLE 191

GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 192

CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 193

CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 194

NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 195

EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 196

ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 197

LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 198

MIDDLE EAST: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 199

GCC COUNTRIES: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 200

SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 201

NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 202

EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 203

ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 204

LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 205

MIDDLE EAST: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 206

GCC COUNTRIES: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 207

FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 208

NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 209

EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 210

ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 211

LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 212

MIDDLE EAST: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 213

GCC COUNTRIES: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 214

MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 215

NORTH AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 216

EUROPE: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 217

ASIA PACIFIC: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 218

LATIN AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 219

MIDDLE EAST: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 220

GCC COUNTRIES: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 221

CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 222

CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 223

NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 224

EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 225

ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 226

LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 227

MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 228

GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 229

CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 230

CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 231

NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 232

EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 233

ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 234

LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 235

MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION)

TABLE 236

GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 237

CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 238

NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 239

EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 240

ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 241

LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 242

MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 243

GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 244

CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 245

NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 246

EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 247

ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 248

LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 249

MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION)

TABLE 250

GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 251

CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION)

TABLE 252

NORTH AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 253

EUROPE: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 254

ASIA PACIFIC: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 255

LATIN AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 256

MIDDLE EAST: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION)

TABLE 257

GCC COUNTRIES: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 258

CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 259

NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 260

EUROPE: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 261

ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 262

LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 263

MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)

TABLE 264

GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 265

CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)

TABLE 266

NORTH AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 267

EUROPE: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 268

ASIA PACIFIC: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 269

LATIN AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 270

MIDDLE EAST: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)

TABLE 271

GCC COUNTRIES: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 272

CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)

TABLE 273

NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 274

EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 275

ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 276

LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 277

MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)

TABLE 278

GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 279

CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION)

TABLE 280

NORTH AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 281

EUROPE: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 282

ASIA PACIFIC: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 283

LATIN AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 284

MIDDLE EAST: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION)

TABLE 285

GCC COUNTRIES: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 286

CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 287

CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 288

NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 289

EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 290

ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 291

LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 292

MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 293

GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 294

CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 295

NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 296

EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 297

ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 298

LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 299

MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)

TABLE 300

GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 301

CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 302

NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 303

EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 304

ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 305

LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 306

MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)

TABLE 307

GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 308

CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 309

NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 310

EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 311

ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 312

LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 313

MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)

TABLE 314

GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 315

CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 316

NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 317

NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 318

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 319

NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 320

NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 321

NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 322

NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 323

NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 324

NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 325

NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 326

NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 327

NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 328

US: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 329

US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 330

US: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 331

US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 332

US: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 333

US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 334

US: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 335

US: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 336

US: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 337

US: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 338

US: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 339

CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 340

CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 341

CANADA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 342

CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 343

CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 344

CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 345

CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 346

CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 347

CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 348

CANADA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 349

CANADA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 350

EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 351

EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 352

EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 353

EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 354

EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 355

EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 356

EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 357

EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 358

EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 359

EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 360

EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 361

EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 362

GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 363

GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 364

GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 365

GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 366

GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 367

GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 368

GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 369

GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 370

GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 371

GERMANY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 372

GERMANY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 373

UK: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 374

UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 375

UK: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 376

UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 377

UK: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 378

UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 379

UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 380

UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 381

UK: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 382

UK: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 383

UK: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 384

FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 385

FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 386

FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 387

FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 388

FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 389

FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 390

FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 391

FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 392

FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 393

FRANCE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 394

FRANCE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 395

ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 396

ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 397

ITALY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 398

ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 399

ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 400

ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 401

ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 402

ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 403

ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 404

ITALY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 405

ITALY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 406

SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 407

SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 408

SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 409

SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 410

SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 411

SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 412

SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 413

SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 414

SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 415

SPAIN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 416

SPAIN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 417

REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 418

REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 419

REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 420

REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 421

REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 422

REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 423

REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 424

REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 425

REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 426

REST OF EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 427

REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 428

ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 429

ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 430

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 431

ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 432

ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 433

ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 434

ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 435

ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 436

ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 437

ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 438

ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 439

ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 440

CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 441

CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 442

CHINA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 443

CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 444

CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 445

CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 446

CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 447

CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 448

CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 449

CHINA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 450

CHINA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 451

JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 452

JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 453

JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 454

JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 455

JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 456

JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 457

JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 458

JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 459

JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 460

JAPAN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 461

JAPAN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 462

INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 463

INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 464

INDIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 465

INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 466

INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 467

INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 468

INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 469

INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 470

INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 471

INDIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 472

INDIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 473

AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 474

AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 475

AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 476

AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 477

AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 478

AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 479

AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 480

AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 481

AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 482

AUSTRALIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 483

AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 484

SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 485

SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 486

SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 487

SOUTH KOREA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 488

SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 489

SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 490

SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 491

SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 492

SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 493

SOUTH KOREA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 494

SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 495

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 496

REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 497

REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 498

REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 499

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 500

REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 501

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 502

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 503

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 504

REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 505

REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 506

LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 507

LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 508

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 509

LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 510

LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 511

LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 512

LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 513

LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 514

LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 515

LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 516

LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 517

LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 518

BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 519

BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 520

BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 521

BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 522

BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 523

BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 524

BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 525

BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 526

BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 527

BRAZIL: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 528

BRAZIL: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 529

MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 530

MEXICO: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 531

MEXICO: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 532

MEXICO: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 533

MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 534

MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 535

MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 536

MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 537

MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 538

MEXICO: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 539

MEXICO: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 540

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 541

REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 542

REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 543

REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 544

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 545

REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 546

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 547

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 548

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 549

REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 550

REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 551

MIDDLE EAST: CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)

TABLE 552

MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 553

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 554

MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 555

MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 556

MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 557

MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 558

MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 559

MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 560

MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 561

MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 562

MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 563

GCC COUNTRIES: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)

TABLE 564

GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 565

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 566

GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 567

GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 568

GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 569

GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 570

GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 571

GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 572

GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 573

GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 574

GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 575

SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 576

SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 577

SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 578

SAUDI ARABIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 579

SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 580

SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 581

SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 582

SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 583

SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 584

SAUDI ARABIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 585

SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 586

UAE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 587

UAE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 588

UAE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 589

UAE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 590

UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 591

UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 592

UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 593

UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 594

UAE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 595

UAE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 596

UAE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 597

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 598

REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 599

REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 600

REST OF GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 601

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 602

REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 603

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 604

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 605

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 606

REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 607

REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 608

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 609

REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 610

REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 611

REST OF MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 612

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 613

REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 614

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 615

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 616

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 617

REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 618

REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 619

AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)

TABLE 620

AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 621

AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 622

AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)

TABLE 623

AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)

TABLE 624

AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 625

AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)

TABLE 626

AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)

TABLE 627

AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)

TABLE 628

AFRICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)

TABLE 629

AFRICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)

TABLE 630

OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026

TABLE 631

CELL ISOLATION MARKET: DEGREE OF COMPETITION

TABLE 632

CELL ISOLATION MARKET: REGION FOOTPRINT

TABLE 633

CELL ISOLATION MARKET: PRODUCT FOOTPRINT

TABLE 634

CELL ISOLATION MARKET: CELL TYPE FOOTPRINT

TABLE 635

CELL ISOLATION MARKET: END-USER FOOTPRINT

TABLE 636

CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES

TABLE 637

CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES

TABLE 638

CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 639

CELL ISOLATION MARKET: DEALS, JANUARY 2023–APRIL 2026

TABLE 640

CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 641

DANAHER CORPORATION: COMPANY OVERVIEW

TABLE 642

DANAHER CORPORATION: PRODUCTS OFFERED

TABLE 643

DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026

TABLE 644

MERCK KGAA: COMPANY OVERVIEW

TABLE 645

MERCK KGAA: PRODUCTS OFFERED

TABLE 646

MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026

TABLE 647

MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 648

THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW

TABLE 649

THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED

TABLE 650

THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 651

THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 652

THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 653

BD: COMPANY OVERVIEW

TABLE 654

BD: PRODUCTS OFFERED

TABLE 655

BD: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 656

BD: DEALS, JANUARY 2023–APRIL 2026

TABLE 657

AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW

TABLE 658

AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED

TABLE 659

AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026

TABLE 660

SARTORIUS AG: COMPANY OVERVIEW

TABLE 661

SARTORIUS AG: PRODUCTS OFFERED

TABLE 662

BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW

TABLE 663

BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 664

BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 665

QIAGEN: COMPANY OVERVIEW

TABLE 666

QIAGEN: PRODUCTS OFFERED

TABLE 667

QIAGEN: DEALS, JANUARY 2023–APRIL 2026

TABLE 668

F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW

TABLE 669

F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED

TABLE 670

F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2023–APRIL 2026

TABLE 671

REVVITY: COMPANY OVERVIEW

TABLE 672

REVVITY: PRODUCTS OFFERED

TABLE 673

CORNING INCORPORATED: COMPANY OVERVIEW

TABLE 674

CORNING INCORPORATED: PRODUCTS OFFERED

TABLE 675

LONZA: COMPANY OVERVIEW

TABLE 676

LONZA: PRODUCTS OFFERED

TABLE 677

BIO-TECHNE: COMPANY OVERVIEW

TABLE 678

BIO-TECHNE: PRODUCTS OFFERED

TABLE 679

TERUMO CORPORATION: COMPANY OVERVIEW

TABLE 680

TERUMO CORPORATION: PRODUCTS OFFERED

TABLE 681

MILTENYI BIOTEC: COMPANY OVERVIEW

TABLE 682

MILTENYI BIOTEC: PRODUCTS OFFERED

TABLE 683

TAKARA BIO INC.: COMPANY OVERVIEW

TABLE 684

TAKARA BIO INC.: PRODUCTS OFFERED

TABLE 685

GENSCRIPT: COMPANY OVERVIEW

TABLE 686

GENSCRIPT: PRODUCTS OFFERED

TABLE 687

GENSCRIPT: DEALS, JANUARY 2023–APRIL 2026

TABLE 688

SONY CORPORATION: COMPANY OVERVIEW

TABLE 689

SONY CORPORATION: PRODUCTS OFFERED

TABLE 690

ALFA LAVAL: COMPANY OVERVIEW

TABLE 691

ALFA LAVAL: PRODUCTS OFFERED

TABLE 692

ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026

TABLE 693

ALFA LAVAL: DEALS, JANUARY 2023–APRIL 2026

TABLE 694

PROMEGA CORPORATION: COMPANY OVERVIEW

TABLE 695

CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW

TABLE 696

MICAREO INC.: COMPANY OVERVIEW

TABLE 697

APPLIED CELLS, INC.: COMPANY OVERVIEW

TABLE 698

STEMCELL TECHNOLOGIES: COMPANY OVERVIEW

TABLE 699

CREATIVE BIOARRAY: COMPANY OVERVIEW

TABLE 700

PROTEINTECH GROUP, INC.: COMPANY OVERVIEW

TABLE 701

MAGBIO GENOMICS, INC.: COMPANY OVERVIEW

TABLE 702

AKADEUM LIFE SCIENCES: COMPANY OVERVIEW

TABLE 703

PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW

TABLE 704

INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW

TABLE 705

IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

TABLE 706

RISK ASSESSMENT

FIGURE 1

CELL ISOLATION MARKET SEGMENTATION & REGIONS CONSIDERED

FIGURE 2

CELL ISOLATION MARKET: YEARS CONSIDERED

FIGURE 4

GLOBAL CELL ISOLATION MARKET, 2024–2031

FIGURE 5

MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, 2023–2026

FIGURE 6

DISRUPTIONS INFLUENCING GROWTH OF CELL ISOLATION MARKET

FIGURE 7

HIGH-GROWTH SEGMENTS IN CELL ISOLATION MARKET, 2026–2031

FIGURE 8

ASIA PACIFIC TO REGISTER HIGHEST CAGR IN CELL ISOLATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD

FIGURE 9

RISING ADOPTION OF STEM CELL RESEARCH AND IMMUNOLOGY RESEARCH TO DRIVE MARKET GROWTH

FIGURE 10

CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF CELL ISOLATION MARKET IN NORTH AMERICA IN 2025

FIGURE 11

ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL CELL ISOLATION MARKET DURING FORECAST PERIOD

FIGURE 12

CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD

FIGURE 13

CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

FIGURE 14

CELL ISOLATION MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 15

CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS

FIGURE 16

CELL ISOLATION MARKET: ECOSYSTEM ANALYSIS

FIGURE 17

AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY KEY PLAYER, 2025 (USD)

FIGURE 18

AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY KEY PLAYER, 2025 (USD)

FIGURE 19

AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY REGION, 2025 (USD)

FIGURE 20

AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY REGION, 2025 (USD)

FIGURE 21

CELL ISOLATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

FIGURE 22

INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION)

FIGURE 23

PATENT APPLICATIONS IN CELL ISOLATION MARKET, JANUARY 2015–DECEMBER 2025

FIGURE 24

IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET

FIGURE 25

INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT

FIGURE 26

KEY BUYING CRITERIA, BY END USER

FIGURE 27

NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT

FIGURE 28

ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT

FIGURE 29

REVENUE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2021–2025 (USD MILLION)

FIGURE 30

MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2025

FIGURE 31

CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025

FIGURE 32

CELL ISOLATION MARKET: COMPANY FOOTPRINT

FIGURE 33

CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025

FIGURE 34

YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS

FIGURE 35

EV/EBITDA OF KEY VENDORS

FIGURE 36

CELL ISOLATION MARKET: BRAND COMPARISON

FIGURE 37

DANAHER CORPORATION: COMPANY SNAPSHOT (2025)

FIGURE 38

MERCK KGAA: COMPANY SNAPSHOT (2025)

FIGURE 39

THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)

FIGURE 40

BD: COMPANY SNAPSHOT (2025)

FIGURE 41

AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)

FIGURE 42

SARTORIUS AG: COMPANY SNAPSHOT (2025)

FIGURE 43

BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)

FIGURE 44

QIAGEN: COMPANY SNAPSHOT (2025)

FIGURE 45

F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)

FIGURE 46

REVVITY: COMPANY SNAPSHOT (2025)

FIGURE 47

CORNING INCORPORATED: COMPANY SNAPSHOT (2025)

FIGURE 48

LONZA: COMPANY SNAPSHOT (2025)

FIGURE 49

BIO-TECHNE: COMPANY SNAPSHOT (2025)

FIGURE 50

TERUMO CORPORATION: COMPANY SNAPSHOT (2024)

FIGURE 51

TAKARA BIO INC.: COMPANY SNAPSHOT (2024)

FIGURE 52

GENSCRIPT: COMPANY SNAPSHOT (2025)

FIGURE 53

SONY CORPORATION: COMPANY SNAPSHOT (2024)

FIGURE 54

ALFA LAVAL: COMPANY SNAPSHOT (2025)

FIGURE 55

CELL ISOLATION MARKET: RESEARCH DESIGN

FIGURE 56

CELL ISOLATION MARKET: BREAKDOWN OF PRIMARIES

FIGURE 57

CELL ISOLATION MARKET: INSIGHTS FROM PRIMARIES

FIGURE 58

GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025

FIGURE 59

CELL ISOLATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)

FIGURE 60

ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025)

FIGURE 61

SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH

FIGURE 62

CELL ISOLATION MARKET: CAGR PROJECTIONS

FIGURE 63

CELL ISOLATION MARKET: DATA TRIANGULATION

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect information for analysis of the global cell isolation market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with primary research inputs to determine the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the cell isolation market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), American Filtration and Separations Society (AFS), Food and Drug Administration (FDA), American Society for Cell Biology (ASC8), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Pharmaceutical Research and Manufacturers of America (PhRMA), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Alliance for Regenerative Medicine (ARM). Secondary data were collected and analyzed to determine the overall size of the global cell isolation market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

Data Center Storage Market
Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate & validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various market segments.

Cell Isolation Market/Cell Separation Market : Top-Down and Bottom-Up Approach

Cell Isolation Market/Cell Separation Market Top Down and Bottom Up Approach

Data Triangulation

After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

Market Definition

Cell isolation is the process of separating specific cells from a given sample. It is a tool in biological research that enables the isolation of a single cell type from heterogeneous cell populations without contamination by other cell types. This process is widely used for the isolation of biomolecules to produce vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Key Stakeholders

Pharmaceutical & biotechnology companies
Contract research organizations (CROs)
Life science companies
Academic & research institutes
Private research institutes
Venture capitalists & investors
Hospitals and diagnostic laboratories
Market research & consulting firms
Medical institutions & universities

Report Objectives

To define, describe, and forecast the cell isolation market based on product, cell type, cell source, technique, application, end user, and region
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall cell isolation market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To strategically profile the key players in the cell isolation market and comprehensively analyze their core competencies and market rankings
To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the cell isolation market
To benchmark players within the cell isolation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

Customization Options :

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

Further breakdown of the Rest of Europe Cell Isolation Market, by country
Further breakdown of the Rest of Asia Pacific Cell Isolation Market, by country
Further breakdown of the Rest of Latin America Cell Isolation Market, by country
Further breakdown of the Rest of Middle East Cell Isolation Market, by country

Personalize This Research

Triangulate with your Own Data
Get Data as per your Format and Definition
Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
Any level of Personalization

Request A Free Customisation

Let Us Help You

What are the Known and Unknown Adjacencies Impacting the Cell Isolation Market/ Cell Separation Market
What will your New Revenue Sources be?
Who will be your Top Customer; what will make them switch?
Defend your Market Share or Win Competitors
Get a Scorecard for Target Partners

Customized Workshop Request

JAYANT RAJPUROHIT

Director of Market Insights, Data and Analytics

SFI Health,

Leading Pharmaceutical Company

www.sfihealth.com/

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE

Head of Commercial Analytics

Qualicaps,

Leading Pharmaceutical Company

www.qualicaps.com/

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,

Senior Director Business Development & Innovation

Bracco Diagnostics Inc.,

Italian Multinational in life sciences sector and a World Leader in imaging diagnostics

imaging.bracco.com/us-en

We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,

Market Development and Strategy Manager

3M Health Information Systems,

Leader in Health care Coding, Payment & Analytics Solutions.

www.3m.com/3M/en_US/health-information-systems-us

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.

Their customer first approach and high value engagement model, have given us great analysis and excellent value for money

Previous Next

推荐订阅源

Market Research Reports

Cell Isolation Market/ Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

CELL ISOLATION MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

CELL ISOLATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: CELL ISOLATION MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Cell Isolation Market/Cell Separation Market : Top-Down and Bottom-Up Approach

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Customization Options :

Geographical Analysis

Company Information

Personalize This Research

Let Us Help You

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,